Effect of PCOS on omentin-1, androgens, biochemical glycemic and lipid profile in pubertal girls with normal body mass index
Study question: What is the role of Omentin-1 and the serum levels of androgens, glycemiclipidemic markers in normal body mass index (BMI) pubertal girls with polycystic ovary syndrome (PCOS) compared with matched controls?
Summary answer: The negative cardiovascular effects of PCOS most likely begin as early as puberty, even in the presence of a normal BMI. Additionally, the association of PCOS and omentin-1 is more complex than previously thought and appears to regulate metabolism differently during puberty.
What is known already: Omentin-1 levels may be predictive of the metabolic consequences associated with PCOS patients. However, plasma levels of omentin-1 in patients with normal BMI are not as consistent as has been demonstrated in overweight or obese PCOS patients. To our knowledge; metabolic parameters, the relationship between omentin-1 and PCOS in pubertal girls has not been previously reported. Understanding the pathophysiological triggers that occur during puberty will benefit the future health of pubertal girls with PCOS.
Study design, size, duration: In this cross-sectional study we studied with 63 pubertal girls with PCOS and 159 matched controls. In all of the participants BMI was less than 25 kg/m2. Participants/materials, setting, methods: The diagnosis of PCOS was based on the recent ESHRE/ASRM proposal and required that all three of the Rotterdam criteria for diagnosing PCOS in adolescents be met. Indices of insulin sensitivity, metabolic variables, circulating androgen levels, lipidemic markers and serum omentin-1 levels were measured.
Main results and the role of chance: Blood pressure parameters (systolic/diastolic) were significantly higher in girls with PCOS (112. 44 mmHg vs. 104. 49 mmHg; p<0,001 for systolic BP / 74. 12 mmHg vs. 69. 01 mmHg; p<0,007 for diastolic BP). There was no significant difference in the plasma levels of fasting glucose, total cholesterol, HDL, apo-A1 and SHBG in girls with PCOS compared to the control group.
Conversely, girls with PCOS had higher fasting insulin (p=0.007), LDL (p=0.017), triglyceride (p=0.045), apoB (p<0.001), total (p<0.001) and free testosterone (p=0.001) and omentin-1 (p=0.018) levels compared to control group. Additionally apoB/apoA1 (p=0.021) and FAI (p=0.004) values were significantly higher in girls with PCOS compared to the control group.
Limitations, reasons for caution: Cross sectional design of our study is main limitation. Longterm studies of girls with PCOS that begin during puberty will give us more knowledge about the regulation and effect of omentin-1 in PCOS.
Wider implications of the findings: Even in the presence of a normal BMI, decreased ApoB and increased ApoA1 levels in girls with PCOS may be an early sign of impending metabolic dysfunction and increased cardiovascular risk. Additonally, Omentin-1 regulation is multifactorial and dependent on mechanisms other than BMI and IR that have yet to be identified, at least in pubertal girls with normal BMI.
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